PFKFB3 and metabolic dysfunction-associated steatotic liver disease: In PFKFB3-deficient macrophages, the inhibitory impact of indole on LPS-induced p-p46 and p-NF-κB p65 was nullified, lowering the efficacy of indole in the treatment of NAFLD (Ma et al., 2020).